Arcturus Therapeutics Holdings Inc.
ARCT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001768224
No open-market purchases or sales by Arcturus Therapeutics Holdings Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $167.9M in total; ARK Invest is the only superinvestor holding it.
Q1 2022 vs. Q4 2021
How the institutions holding Arcturus Therapeutics Holdings Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 139 | 1 | 129 | −9 |
| Shares | 20.0M | 131 | 21.4M | +1.49M (+7.5%) |
| Value | $736.2M | $5.00K | $578.1M | −$158.1M (−21.5%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Asset Management, L.P. | 425,200 | $11.5M | 0.05% |
| Los Angeles Capital Management LLC | 59,630 | $1.61M | 0.01% |
| Capital Fund Management S.A. | 34,926 | $941.6K | 0.03% |
| IndexIQ Advisors LLC | 14,183 | $382.0K | 0.01% |
| NinePointTwo Capital | 12,417 | $334.0K | 0.09% |
| E Fund Management Co., Ltd. | 11,910 | $321.0K | 0.01% |
| Bayesian Capital Management, LP | 8,300 | $224.0K | 0.03% |
| Cubist Systematic Strategies, LLC | 5,235 | $141.0K | 0.00% |
| Amalgamated Bank | 2,542 | $69.0K | 0.00% |
| Amalgamated Financial Corp. | 2,542 | $69.0K | 0.00% |
| Old Second National Bank of Aurora | 200 | $5.00K | 0.00% |
| Point72 Hong Kong Ltd | 173 | $5.00K | 0.00% |
| Prospera Financial Services Inc | 100 | $3.00K | 0.00% |
| Allworth Financial LP | 100 | $3.00K | 0.00% |
| Quadrant Capital Group LLC | 21 | $1.00K | 0.00% |
| Glassman Wealth Services | 1 | $0 | 0.00% |
Sold out (25)
Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
Not filed for Q1 2022 yet (1)
Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Carroll Financial Associates, Inc. | 131 | $5.00K |